Answers are grounded in this paper and cite their sources.
Prospective analysis links albuminuria with higher rates of cardiovascular events and bleeding in patients with vascular disease, suggesting its significance as a prognostic marker.
Aim . To assess the significance of albuminuria in predicting prognosis-determining events (cardiovascular (CVEs) and hemorrhagic events) in patients with multifocal atherosclerosis, including in comparison with the generally accepted endothelial dysfunction laboratory marker — von Willebrand factor (VWF). Material and methods . The study included participants of the single-center prospective registry REGATA-1 with coronary and peripheral artery disease. The albumin-to-creatinine ratio in a single morning urine sample and plasma VWF activity were determined. The primary endpoint was the sum of following prognosis-determining events: myocardial infarction, unstable angina, stroke, transient ischemic attack, peripheral artery disease, amputation, major/clinically significant bleeding (BARC 2-5). Results . A total of 148 patients were included (median age 66 [65; 67] years, 79,1% men). An increase in the urine albumin level (at least mild, >10 mg/g) was detected in 71,3% of patients. Median follow-up duration was 17 [15; 20] months; 7 CVEs and 18 BARC 2-3 bleedings were registered. ROC analysis revealed the albuminuria cutoff point of 10,6 mg/g, values above which are associated with an increase in the rate of prognosis-determining events. These events were registered in 4,5% of patients with albuminuria <10,6 mg/g and in 21,9% of patients with higher values (p log-rank =0,007). According to multivariate analysis, the odds ratio (OR) was 5,5 (95% confidence interval (CI) 1,23-24,72), p=0,026. When analyzing secondary endpoints, a trend towards an increase in the risk of CVEs (p=0,065) and hemorrhagic events (p=0,05) was noted. In this cohort, no association was demonstrated between the glomerular filtration rate and the risk of prognosis-determining events. The cutoff point for VWF was 157%. The incidence of prognosis-determining events was significantly higher in individuals with elevated VWF (23,0% vs 10,8%, p=0,048). In multivariate analysis, VWF lost its significance (OR 2,18; 95% CI 0,84-5,65; p=0,11). In 31,2% of patients, there was a simultaneous increase in albuminuria and VWF, and in this subgroup every third person had prognosis-determining events; in multivariate analysis, the OR was 3,53 (95% CI 1,31-9,49), p=0,012. The combined marker is associated with an increased risk of hemorrhagic events (p=0,006) and CVEs (p=0,027). Conclusion . In patients with multifocal atherosclerosis, albuminuria >10,6 mg/g is an independent (including from the estimated glomerular filtration rate) predictor of CVEs and hemorrhagic events. The most unfavorable prognosis is in patients with a combination of albuminuria >10,6 mg/g and EF >157%.
No takes yet. Share an insight, caveat, or question.
Шахматова et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: